Peter Stein Healthcare News

This is selected healthcare news for Peter Stein, which is filed under People. There are 34 news items for this page.

Please provide a valid email address.

Selected Headlines

Date Headline (link) Source
11/28/2022 From eID wallets to soulbound tokens: future-proofing digital identity
... with Web3. Digital IDs (eIDs) are the new currency ‚AuOn the internet, nobody knows you are a dog,‚Au quoted in a famous cartoon by Peter Steiner in 1993, continues to be relevant even now as Web3 and the metaverse emerge as the future of our online world. Our digital ...
fintechfutures.com
10/19/2022 Expert advisers urge FDA to pull pregnancy drug from market
... Get the full experience. Choose your plan ArrowRight But FDA experts and others said the data does not support such a view. In closing arguments, Peter Stein, director of the Office of New Drugs at the FDA's Center for Drug Evaluation and Research, agreed on the urgent need for ...
The Washington Post
10/19/2022 Expert advisers urge FDA to pull pregnancy drug from market
Peter Stein, director of the Office of New Drugs at the FDA's Center for Drug Evaluation and Research, acknowledged in closing arguments clinicians‚Ao arguments about the need for an effective drug to reduce the incidence of preterm birth a leading cause of infant mortality in the United ...
google.com
10/19/2022 FDA advisory committee recommends stopping sale of Makena, a preterm birth drug
... voted no on whether the drug was effective, whether trial data support its approval and whether the drug should remain available on the market. Advertisement Peter Stein directs the FDA's Office of New Drugs at the Center For Drug Evaluation and Research. "Hope is a reason to keep looking for ...
upi.com
9/21/2022 [Audio] #WorkforceWednesday: Spilling Secrets: Employers - Train on Trade Secrets - Employment Law This Week®
... type of training can be critical for employers in protecting trade secrets and avoiding litigation in the future. Our all-star panel of attorneys ‚Ai Peter Steinmeyer, Kate Rigby, Millie Warner, and Erik W. Weibust ‚Ai discuss more. Employment Law This Week¬AE gives a rundown of the top developments ...
JD Supra
8/31/2022 [Audio] #WorkforceWednesday: Spilling Secrets: Restrictive Covenants in the Remote Work Boom - Employment Law This Week®
... Spilling Secrets episode, hear how employers are addressing restrictive covenant concerns now that employees may be located anywhere. Our all-star panel of attorneys ‚Ai Peter Steinmeyer, Kate Rigby, Millie Warner, and Erik W. Weibust ‚Ai discuss more. Employment Law This Week¬AE gives a rundown of the top developments ...
JD Supra
10/1/2021 Medical News Forecast for October 4-10
... share perspectives on what success and equilibrium will look like. The goal is to build global strategies to continue the growth of the biosimilars market. Peter Stein, MD, director of the FDA's Office of New Drugs, will be a keynote speaker, and several other FDA officials also will speak ...
Physicians Weekly
9/29/2021 What happens if pro-lifers get their Supreme Court wishes?
In a long, somewhat rambling piece about the bishops and abortion appearing in the September issue of Commonweal, Peter Steinfels makes a crucial point. It's been made before by others, but it bears repeating at this moment when the Supreme Court, in the term beginning Oct. 4, is widely ...
angelusnews.com
9/6/2021 Rosh Hashanah, Yom Kippur services adapt to delta variant
... a place for people to find emotional connection to find support and sometimes that's in creative ways like doing things online,‚Au said Rabbi Peter Stein, ‚Aubut it is a way of hopefully comforting people whether it's directly with a loss or whether just living with the stress ...
wxxinews.org
3/22/2021 More than 300 COVID-19 Trials Reviewed by FDA's New Drugs Office in 2020 | 2021-03-21 | CenterWatch
... to the report, OND contributed to the authorization of seven Emergency Use Authorizations for COVID-19 vaccines and treatments between March and December 2020, said Peter Stein, OND's director. OND also completed a restructuring initiative in 2020, creating eight new offices focused on broad therapeutic areas, such as neuroscience ...
centerwatch.com
3/19/2021 OND Managed a Slew of EUAs, a Reorg, PDUFA Goals and Regular Business During Pandemic, Says Annual Report
... in 2020, the office approved 53 novel drugs, published 31 new guidances and wrapped up the reorganization it had been working on since 2019, said Peter Stein, OND's director, in the office's annual report. ‚AuThe outbreak of COVID-19 presented an unprecedented challenge to OND in 2020,‚Au ...
fdanews.com
3/3/2021 Prison for Opioid Scripts; One Medical in Hot Water; How Docs Paid for Warp Speed
... in North Philadelphia, where he illegally doled out oxycodone and methadone to patients in exchange for sex and money, according to the Department of Justice . Peter Steiner, MD, a psychiatrist in Louisville, Kentucky, was sentenced to 5 years in prison for distributing unnecessary buprenorphine and fentanyl to multiple patients over ...
Medpage Today
2/27/2021 Kentucky doctor sentenced to 5 years for drug dealing charges
A Kentucky psychiatrist was sentenced Friday to five years in prison and three years of supervised probation after pleading guilty last year to dealing drugs. Dr. Peter Steiner, who ran Kentuckiana Mental Health Associates in Louisville, was charged with distributing controlled substances without a medical reason in March of 2018 ...
courier-journal.com
9/4/2020 Advocacy at a Glance
Top-Line: Acting CDER Director Patrizia Cavazzoni, MD, and Director of the Office of New Drugs Peter Stein, MD, have accepted our invitation to speak at a special Alliance webinar, scheduled for September 28. A Continuing Resolution (CR) to continue government funding after October 1 is inevitable. The important details ...
strengthenfda.org
8/22/2020 Details, Fiction and dongek house
... to your noisy bustling street. Incredibly, for me, It's really a remarkably soothing sensation.On July 5th, 1993, The New Yorker published a cartoon by artist Peter Steiner, which highlighted an illustration of the Pet dog seated at a pc telling his canine companion that “on the Internet, no one is ...
fitnell.com
7/21/2020 Chamber aiding in tents situation
Chamber aiding in tents situation July 22, 2020 Peter Stein Workers were busy Tuesday morning constructing canopies for pop-up patios at Leal's Restaurant on Mabry Drive in Clovis. CLOVIS - The roller coaster that is COVID-19 has plunged downward, then upward, then down again for local restaurants. But the ...
easternnewmexiconews.com
6/25/2020 Mask/Off
... The Beach nymag.com For 40 years, the city's lifeguard corps has been mired in controversy, and for 40 years it's been run by one man: Peter Stein. MASK MARAUDER He Removed Labels That Said 'Medical Use Prohibited,' Then Tried To Sell Thousands Of Masks To Officials Who Distribute To Hospitals ...
blogspot.com
3/17/2020 Residents weigh in on virus
Residents weigh in on virus March 18, 2020 Peter Stein The paper products aisle at the Clovis Walmart on Prince Street has been overrun and cleaned out by paper hoarders, a common chain-reaction affect of the coronavirus pandemic at stores throughout the country in recent days. A week ago ...
easternnewmexiconews.com
3/13/2020 Louisville Psychiatrist Pleads Guilty To Distributing Controlled Substances Without A Medical Purpose
LOUISVILLE, Ky. - Louisville psychiatrist Dr. Peter Steiner has pleaded guilty to intentionally distributing schedule II, III, and IV controlled substances, without any legitimate medical purpose and outside the course of professional medical practice, announced United States Attorney Russell Coleman. “This is a crystal clear example of the U.S. Attorney's Office ...
blogspot.com
3/12/2020 Kentucky psychiatrist pleads guilty to dealing drugs
A Kentucky doctor who was previously charged with dealing drugs pleaded guilty on Wednesday. Dr. Peter Steiner pleaded guilty to distributing controlled substances without a medical reason, U.S. Attorney Russell Coleman announced in a statement. A grand jury indicted Steiner in June 2018, charging the Kentuckiana Mental Health Associates psychiatrist ...
courier-journal.com
3/11/2020 Louisville Psychiatrist Dr. Peter Steiner Pleads Guilty To Distributing Controlled Substances Without A Medical Purpose
Publisher 1 ( STL.News ) - Louisville psychiatrist Dr. Peter Steiner has pleaded guilty to intentionally distributing schedule II, III, and IV controlled substances, without any legitimate medical purpose and outside the course of professional medical practice, announced United States Attorney Russell Coleman. “This is a crystal clear example of the U.S. Attorney's ...
stl.news
2/12/2020 Norgine B.V. Enters Into Exclusive Licence and Distribution Agreements for the Commercialisation of PLENVU® in a Number of Countries in Latin America, Southern Africa, Central and Eastern Europe
... Biopharma in Central and Eastern Europe including Bosnia and Herzegovina , Bulgaria , Croatia , Czech Republic , Hungary , Kosovo , Montenegro , North Macedonia , Poland , Romania , Serbia, Slovakia , and Slovenia . Peter Stein , Chairman and Chief Executive Officer of Norgine said, "Colonoscopy plays a critical role in the prevention of gastrointestinal diseases including colorectal cancer. Through ...
PR Newswire
2/12/2020 Norgine B.V. Enters Into Exclusive Licence and Distribution Agreements for the Commercialisation of PLENVU® in a Number of Countries in Latin America, Southern Africa, Central and Eastern Europe
... Biopharma in Central and Eastern Europe including Bosnia and Herzegovina , Bulgaria , Croatia , Czech Republic , Hungary , Kosovo , Montenegro , North Macedonia , Poland , Romania , Serbia, Slovakia , and Slovenia . Peter Stein , Chairman and Chief Executive Officer of Norgine said, "Colonoscopy plays a critical role in the prevention of gastrointestinal diseases including colorectal cancer. Through ...
Yahoo News
1/14/2020 Phase III Of FDA’s OND Reorganization Pushed Back To Jan. 21
Phase III Of FDA's OND Reorganization Pushed Back To Jan. 21 January 13, 2020 at 6:08 PM Tweet The third phase of FDA's Office of New Drugs restructuring has been pushed back from Jan. 13 to Jan. 21, Peter Stein, director of OND, wrote in an email to industry on ...
insidehealthpolicy.com
12/19/2019 Sarepta Wins FDA Approval for Vyondys for Duchenne Muscular Dystrophy
... outlined in relevant FDA Guidance. With the support of the Review Division, the matters raised in the CRL were rapidly evaluated and resolved by Dr. Peter Stein, Director of the Office of New Drugs (OND). OND granted the Company's appeal and Sarepta re-submitted its NDA to the Review Division ...
ispeboston.org